About Cutaneous Lymphoma

Cutaneous Lymphoma Foundation Publishes Summit Proceedings

Thu, 09/09/2010

New “Call To Action” Sets Road Map For Future Research and Treatment

BIRMINGHAM, Mich. (September 9, 2010) – The Cutaneous Lymphoma Foundation has published Proceedings from its 2009 Cutaneous Lymphoma Summit.  The Foundation expects these groundbreaking Proceedings to help shape the future of research into cutaneous lymphomas and the treatment of these blood cancers in the coming years.

The Summit was held October 9-11, 2009 in New York City and included the world’s foremost researchers on cutaneous lymphomas, 36 of whom have authored works in the published Proceedings.

A highlight of the Proceedings is an editorial authored by two leading researchers, Stuart R. Lessin, M.D. of the Fox Chase Cancer Center in Philadelphia, Pennsylvania and Pierluigi Porcu, M.D. of The Ohio State University in Columbus, Ohio. Drs. Lessin and Porcu co-authored an editorial entitled “The State of Cutaneous Lymphomas:  A Call to Action.”

This editorial, based on the sessions held within The Summit, strongly calls for new multidisciplinary collaborations and resources and will serve as a white paper by which progress over future years can be measured.  Categories of specific recommendations in the article include:

  • Research Needs and Opportunities
  • Clinical Care Needs and Opportunities
  • Patient, Physician and Nursing Education Needs and Opportunities

 “The strategic targets outlined in the Proceedings should be rapidly tackled by the cutaneous lymphoma community and be reassessed annually for progress,” said Judy Jones, Co-Founder and President of the Cutaneous Lymphoma Foundation.  “It is my hope that these Proceedings and white paper will spark the creation of a more collaborative research community and that its emergent ideas and commitments will garner greater attention and resources from the public, offering greater hope to patients and families.”


Click here to view/download the SUMMIT PROCEEDINGS PRESS RELEASE.

English French German Italian Portuguese Russian Spanish

This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.